| 000 | 01103 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516085748.0 | ||
| 264 | 0 | _c20121024 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1097-6868 | ||
| 024 | 7 |
_a10.1016/j.ajog.2012.04.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCombs, C Andrew | |
| 245 | 0 | 0 |
_aSource of 17-hydroxyprogesterone caproate in clinical trials. _h[electronic resource] |
| 260 |
_bAmerican journal of obstetrics and gynecology _cAug 2012 |
||
| 300 |
_ae10; author reply e10-1 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyprogesterones _xtherapeutic use |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPremature Birth _xprevention & control |
| 650 | 0 | 4 | _aTocolysis |
| 650 | 0 | 4 |
_aTocolytic Agents _xtherapeutic use |
| 700 | 1 | _aMaurel, Kimberly | |
| 700 | 1 | _aGarite, Thomas J | |
| 773 | 0 |
_tAmerican journal of obstetrics and gynecology _gvol. 207 _gno. 2 _gp. e10; author reply e10-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ajog.2012.04.001 _zAvailable from publisher's website |
| 999 |
_c21703514 _d21703514 |
||